Phone : +8610-67895577
Group Introduction About us Development path Career Opportunities
AK Medical Holding Limited was established in 2003 and listed on the Hong Kong Stock Exchange in 2017 with stock code: 1789.HK. The headquarter is located at No. 10 Baifuquan Road, Changping Science Park, 102200, Beijing, China.
As a leading company in China's orthopedic implant industry, AK Medical has successively obtained NMPA registration certificates for metal 3D printed implants (Hip Joint System, Artificial Vertebral System, Intervertebral Fusion System). In August 2015, the 3D ACT Artificial Hip Joint System was clinically verified and was approved for marketing, and all relevant core technologies have independent intellectual property rights.
The ITI (Image To Implant) technology platform launched by AK Medical is another innovation in the field of 3D printing and digitalization: comprehensive preoperative planning allows doctors to know the possible risks during the operation in advance, which shortens the operation time, improves the accuracy of the operation, and also provides an effective guarantee for the safety of the patient.
In the past ten years, based on 3D ACT technology, AK Medical has successively completed artificial atlantoaxial vertebrae (artificial vertebrae), cervical vertebrae, multi-segment thoracolumbar vertebrae, artificial elbow joint, artificial wrist joint, total knee joint, full sacrum, half pelvis (sacral iliac joint to pubic bone) and many other personalized design prosthesis replacements, which provides surgeons with anatomical reconstruction solutions based on the concept of precision medicine. This provides doctors and patients with wings of imagination, and finally becomes reality!
It is the long-term strategic goal of AK Medical to becomes a leader in orthopedic field in China. In 2018, through the acquisition of a UK company JRI Orthopaedics Ltd, AK Medical has taken an important step in artificial joint surface technology and overseas market expansion; the acquisition of a Medtronic company, Beijing Libeier Bio-engineering Institute Co., Ltd. at the beginning of 2020 is

Corporate Vision

To become a respected world-class medical enterprise through sustainable innovation.

Our Mission

Strive for improve the quality of life of hundreds of millions of patients.

Core Value

Responsibility、 Infinite  pursuit of quality、 Share、 Keep passion